These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33925575)

  • 1. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immune microenvironment in head and neck cancers.
    Chen SMY; Krinsky AL; Woolaver RA; Wang X; Chen Z; Wang JH
    Mol Carcinog; 2020 Jul; 59(7):766-774. PubMed ID: 32017286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.
    Zhang Y; Dong P; Yang L
    Front Immunol; 2023; 14():1189323. PubMed ID: 37292204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
    Freiser ME; Serafini P; Weed DT
    Immunol Res; 2013 Dec; 57(1-3):52-69. PubMed ID: 24218361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.
    Bhat AA; Yousuf P; Wani NA; Rizwan A; Chauhan SS; Siddiqi MA; Bedognetti D; El-Rifai W; Frenneaux MP; Batra SK; Haris M; Macha MA
    Signal Transduct Target Ther; 2021 Jan; 6(1):12. PubMed ID: 33436555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in head and neck cancer.
    Pries R; Wollenberg B
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment in head and neck squamous cell carcinoma.
    Curry JM; Sprandio J; Cognetti D; Luginbuhl A; Bar-ad V; Pribitkin E; Tuluc M
    Semin Oncol; 2014 Apr; 41(2):217-34. PubMed ID: 24787294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma.
    Takahashi H; Sakakura K; Kawabata-Iwakawa R; Rokudai S; Toyoda M; Nishiyama M; Chikamatsu K
    Cancer Immunol Immunother; 2015 Nov; 64(11):1407-17. PubMed ID: 26201938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
    Wang SS; Cen X; Liang XH; Tang YL
    Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytokines in head and neck squamous cell carcinoma.
    Pries R; Nitsch S; Wollenberg B
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1195-203. PubMed ID: 17020454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
    Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
    Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
    Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
    Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.
    Macha MA; Wani NA; Ganai RA; Bhat AA; Hamid A; Hashem S; Haris M; Chauhan SS; Zargar MA; Batra SK
    Adv Exp Med Biol; 2020; 1296():11-31. PubMed ID: 34185284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review.
    Peltanova B; Raudenska M; Masarik M
    Mol Cancer; 2019 Mar; 18(1):63. PubMed ID: 30927923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.